Overactive Bladder (OAB)
49
15
15
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.1%
2 terminated out of 49 trials
90.9%
+4.4% vs benchmark
22%
11 trials in Phase 3/4
30%
6 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (49)
INOPASE - Performance and Safety Study of a Personalised SNM System
Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life
Tensi+ for Treating Overactive Bladder
RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive Bladder
Aquarius Pilot Study to Evaluate the New Axonics Trial System
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .
Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study
Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.
Ease of Use Study of the FemPulse System
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
Early Detection of OAB and Elimination of Negative Impact on Quality of Life
Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder
Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation